nafamostat has been researched along with glycyrrhizic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Cho, T; Han, HS; Jeong, J; Park, EM; Shim, KS | 1 |
| Ahn, SJ; Chokkakula, S; Jeong, JH; Jung, JM; Jung, JW; Kim, BK; Kim, EG; Lee, WH; Min, SC; Oh, S; Park, JH; Park, OB; Song, MS | 1 |
1 review(s) available for nafamostat and glycyrrhizic acid
| Article | Year |
|---|---|
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
2 other study(ies) available for nafamostat and glycyrrhizic acid
| Article | Year |
|---|---|
A Novel Computational Approach for the Discovery of Drug Delivery System Candidates for COVID-19.
Topics: A549 Cells; Anti-Inflammatory Agents; Benzamidines; Cell Survival; Cluster Analysis; Computational Biology; Computer Simulation; COVID-19 Drug Treatment; Databases, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Repositioning; Drug Stability; Glycyrrhizic Acid; Guanidines; Humans; Hydrophobic and Hydrophilic Interactions; Micelles; Microscopy, Electron, Transmission; Molecular Structure; Nanoparticles; Particle Size | 2021 |
Evaluation of the Antiviral Efficacy of Subcutaneous Nafamostat Formulated with Glycyrrhizic Acid against SARS-CoV-2 in a Murine Model.
Topics: Animals; Antiviral Agents; COVID-19; Disease Models, Animal; Glycyrrhizic Acid; Humans; Mice; Pandemics; Rats; Rats, Sprague-Dawley; SARS-CoV-2 | 2023 |